Abstract
The stage A2 carcinoma of the prostate is most commonly discovered incidentally on histological analysis of prostatic tissue removed during transurethral resection (TURP) performed for infravesical obstruction. On this occasion the far-reaching decision must be made whether a symptom-free patient with a tumor of perhaps only minor malignant potency should be subjected to curative, but invasive therapy, or whether to dispense with treatment completely and confine the activities to regular follow-up examinations. No compromise is possible between these two modalities. The final decision must be based on the following considerations. It must be possible to assess the statistical risk of dying from the cancer with a high degree of probability for the overall patient population as well as for the individual patient. The risk of dying from the tumor must be weighed against the risk of therapy including mortality but also the considerable morbidity involved in treatment. Another prerequisite for being able to take the responsibility for a wait-and-see strategy is the availability of diagnostic means for the detection of progression in a curable stage. This very essential problem is discussed here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agatstein EH, Hernandez FJ, Layfield LJ, Smith RB, DeKernion JB (1987) Use of fine needle aspiration for detection of stage A prostatic carcinoma before transurethral resection of the prostate: a clinical trial. J Urol 138:551–553
Allhoff E, deRiese W, Eifinger M, Pethke J, Jonas U (1989) Prostate-specific antigen — comparative clinical appreciation of a serodiagnostic measure after 8 years of experience. World J Urol 7:12–16
Barnes R, Hirst A, Rosenquist R (1976) Early carcinoma of the prostate: comparison of stages A and B. J Urol 115:404–405
Bartsch G, Egender G, Hübscher H, Rohr HP (1982) Sonometrics of the prostate. J Urol 127:1119–1121
Bartsch G, Janetschek G, ZurNedden D (1986) Comparison of rectal sonography, CT scan and NMR in prostatic cancer. J Urol 135:147A
Blute ML, Zincke H, Farrow GM (1986) Long-term follow-up of young patients with stage A adeno-carcinoma of the prostate. J Urol 136:840–843
Bridges CH, Belville WD, Insalaco SJ, Buck AS (1983) Stage A prostatic carcinoma and repeat transurethral resection: a reappraisal 5 years later. J Urol 129:307–308
Brooman PJC, Peeling WB, Griffiths GJ, Roberts E, Evans K (1981) A comparison between digital examination and perrectal ultrasound in the evaluation of the prostate. Br J Urol 53:617–620
Cantrell BB, DeKlerk DP, Eggleston JC, Boitnott JK, Walsh PC (1981) Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. J Urol 125:516–520
Carroll PR, Leitner TC, Benedict Yen TS, Watson RA, Williams RD (1985) Incidental carcinoma of the prostate: significance of staging transurethral resection. J Urol 133:811–814
Cohen JM, Resnick MI (1983) The use of transrectal ultrasonography in the diagnosis of stage A prostatic carcinoma. World J Urol 1:12–14
Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Bass RB Jr, Terry WJ (1988) Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer. J Urol 139:758–761
Donohue RE, Fauver HE, Whitesel JA, Augspurger RR, Pfister RR (1981) Prostatic carcinoma: influence of tumor grade on results of pelvic lymphadenectomy. Urology 17(5):435–440
Egender G, Furtschegger A, Schachtner W, Pirker E, Bartsch G (1986) Transrectal ultrasonography in diagnosis and staging of prostatic cancer. World J Urol 4:163–170
Epstein JI, Pauli G, Eggleston JC, Walsh PC (1986) Prognoses of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended follow-up. J Urol 136:837–839
Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vesella RL (1987) Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 138:1181–1184
Gluck R, Cohen M, Warner R (1989) Transrectal ultrasound in early detection of clinical stage A prostate cancer. Urology 34(1):58–61
Golimbu M, Schinella R, Morales P, Kurusu S (1978) Differences in pathological characteristics and prognosis of clinical A2 prostatic cancer from A1 and B disease. J Urol 119:618–622
Guinan P, Bhatti R, Ray P (1987) An evaluation of prostate specific antigen in prostatic cancer. J Urol 137:686–689
Lee F, Littrup J, Torp-Pedersen ST, Mettlin C, McHugh TA, Gray JM, Kumasaka GH, McLeary RD (1988) Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology 168:389–394
Lowe BA, Listrom MB (1988) Management of stage A prostate cancer with a high probability of progression. J Urol 140:1345–1347
Parfitt HE Jr, Smith JA Jr, Gliedman JB, Middleton RG (1983) Accuracy of staging in A1 carcinoma of the prostate. Cancer 51:2346–2350
Rifkin MD, Choi H (1988) Implications of small, Peripheral hypoechoic lesion in endorectal US of the prostate. Radiology 166:619–622
Sheldon CA, Williams RD, Fraley EE (1980) Incidental carcinoma of the prostate: a review of the literatur and critical reappraisal of classification. J Urol 124:626–631
Siddall JK, Cooper EH, Newling DWW, Robinson MRG, Whelan P (1986) An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate. Eur Urol 12:123–130
Sonda LP, Grossman HB, MacGregor RJ, Gikas PW (1984) Incidental adenocarcinoma of the prostate: the role of repeat transurethral resection in staging. The Prostate 5:141–146
Stamey TA, Kabalin JN (1989) Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. J Urol 141:1070–1075
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Janetschek, G., Bartsch, G. (1991). Follow-up After Transurethral Resection for Stage A Prostatic Cancer. In: Altwein, J.E., Faul, P., Schneider, W. (eds) Incidental Carcinoma of the Prostate. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76129-4_39
Download citation
DOI: https://doi.org/10.1007/978-3-642-76129-4_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76131-7
Online ISBN: 978-3-642-76129-4
eBook Packages: Springer Book Archive